Sen. Cardin at the UM BioPark

Thu Aug 10, 2017
On Aug. 10, 2017, Sen. Ben Cardin held a roundtable discussion with University of Maryland, Baltimore (UMB) leadership, UM BioPark tenants and biomedical industry representatives at the UM BioPark. His remarks on health care policy were in response to comments by Harpoon Medical CEO Bill Niland regarding how innovation such as the firm's mitral valve repair device could reduce heart patients' hospital stays and costs. He was also responding to comments on R&D and related topics by former Congressman Jim Greenwood, president and CEO of the Biotechnology Innovation Organization (BIO). Representing UMB on the roundtable were Bruce Jarrell, MD, chief academic and research officer, senior VP and dean of the Graduate School; Jeffrey Grossi, senior government affairs specialist; Jim Hughes, vice president and chief enterprise & economic development officer; and Jane Shaab, assistant VP for economic development. Hughes and Shaab are also president and senior VP, respectively, of the UMB Health Sciences Research Park Corp., which manages the BioPark. They were joined on the roundtable by David Block, CEO of Gliknik, a BioPark tenant; Rachel King, CEO of GlycoMimetics and a member of the BioPark board; Danny Ly, director of public policy and government relations, BD ; Charles H. Fritts, senior director federal government relations, BIO; and Ann Jacobs, senior advisor to the senator.